Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 27 | Kevin HernRJoint | Sale | SELL | $1,001 – $15K |
| Sep 1, 2026 traded Aug 13, 2026 |
| 27 | West NadjaDirector | Open-market sale · 10b5-1 plan | SELL | $207K 3,000 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 26 | Lacerte Rene A.Director, CEO | Tax withholding | F | $1.25M 24.9K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 26 | Kevin HernRJoint | Sale | SELL | $50K – $100K | Sep 1, 2026 traded Aug 24, 2026 |
| 25 | Kevin HernRJoint | Sale | SELL | $1,001 – $15K | Sep 1, 2026 traded Aug 10, 2026 |
| 25 | Kevin HernRJoint | Sale | SELL | $1,001 – $15K | Sep 1, 2026 traded Aug 5, 2026 |
| 25 | Deloach Dennis Reppard IIIDirector | Other acquisition or disposition | J | $50K 50 sh | Sep 1, 2026 traded Aug 13, 2026 |
| 25 | DeLuca John GarrettCFO | Open-market purchase | BUY | $1,445 105 sh | Sep 1, 2026 traded Aug 31, 2026 |
| 25 | Remer Eric RichardDirector | Open-market sale | SELL | $390K 47.4K sh | Sep 1, 2026 traded Sep 1, 2026 |
| 25 | Remer Eric RichardDirector | Open-market sale | SELL | $365K 40.9K sh | Sep 1, 2026 traded Aug 31, 2026 |
| 25 | Politis ChristosDirector | Other acquisition or disposition | J | $50K 50 sh | Sep 1, 2026 traded Aug 13, 2026 |
| 25 | Kevin HernRJoint | Sale | SELL | $1,001 – $15K | Sep 1, 2026 traded Aug 5, 2026 |
| 25 | Kevin HernRSelf | Partial sale | SELL | $1,001 – $15K | Sep 1, 2026 traded Aug 13, 2026 |
| 24 | Donald S. Beyer, Jr.DJoint | Washington St Various 5.00% 08/01/30 Exchange | EXCH | $50K – $100K | Sep 1, 2026 traded Aug 3, 2026 |
| 24 | Hamble International Inc.10% Owner | Small acquisition | L | $5,023 1,732 sh | Sep 1, 2026 traded Jun 30, 2026 |
| 24 | Hamble International Inc.10% Owner | Small acquisition | L | $5,023 1,732 sh | Sep 1, 2026 traded Jun 30, 2026 |
| 24 | Koepke Bryon LVP,General Counsel & Secretary | Open-market sale | SELL | $50K 2,848 sh | Sep 1, 2026 traded Aug 31, 2026 |
| 24 | Kevin HernRJoint | Sale | SELL | $15K – $50K | Sep 1, 2026 traded Aug 19, 2026 |
| 24 | Kevin HernRJoint | Partial sale | SELL | $15K – $50K | Sep 1, 2026 traded Aug 14, 2026 |
| 24 | Kevin HernRJoint | Sale | SELL | $15K – $50K | Sep 1, 2026 traded Aug 13, 2026 |
| 24 | Kevin HernRJoint | Sale | SELL | $15K – $50K | Sep 1, 2026 traded Aug 10, 2026 |
| 24 | Lilly III John OsborneDirector | Other acquisition or disposition | J | — 330.3K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 23 | Sousa Mauad BrunoDirector | Open-market sale | SELL | $5.56M 200.0K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 23 | Britt Christopher RDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $387K 11.4K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 23 | Dignan AndyPresident | Open-market sale · 10b5-1 plan | SELL | $622K 17.8K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 22 | Spoor Bradly WilliamDirector | Other acquisition or disposition | J | $10K 10 sh | Sep 1, 2026 traded Aug 13, 2026 |
| 22 | Moore H Lynn JrDirector, President and CEO | Option exercise | M | $1.90M 9,250 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 22 | Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER | Open-market purchase | BUY | $120 10 sh | Sep 1, 2026 traded Aug 31, 2026 |
| 22 | Simon EliDirector, CEO/PRESIDENT/COO | Tax withholding | F | $1.25M 5,821 sh | Sep 1, 2026 traded Aug 31, 2026 |
| 22 | Williams Jennifer A.SVP, Chief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $90K 1,070 sh | Sep 1, 2026 traded Aug 31, 2026 |
| 22 | Oliver Robin LeighDirector, COO | Other acquisition or disposition | J | $10K 10 sh | Sep 1, 2026 traded Aug 13, 2026 |
| 22 | Blum AlexanderSVP, Chief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $1.37M 31.6K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 22 | Remer Eric RichardDirector | Open-market sale | SELL | $220K 23.8K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 22 | Ericson Brady DDirector, President and CEO | Tax withholding | F | $2.14M 31.2K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 22 | Xu Cong ClaireEVP, Clinical Development | Open-market sale | SELL | $2,593 3,282 sh | Sep 1, 2026 traded Aug 31, 2026 |
| 21 | Lowe JohnDirector, President and CEO | Option exercise | M | — 8,704 sh | Sep 1, 2026 traded Aug 29, 2026 |
| 21 | Vollmer SonyaChief Human Resources Officer | Option exercise | M | — 645 sh | Sep 1, 2026 traded Aug 29, 2026 |
| 21 | Dragovich DarrenChief Legal/Compliance Officer | Option exercise | M | — 785 sh | Sep 1, 2026 traded Aug 29, 2026 |
| 21 | Thompson AnntoinetteChief Operating Officer | Option exercise | M | — 1,150 sh | Sep 1, 2026 traded Aug 29, 2026 |
| 21 | O'Leary MargaretChief Commercial Officer | Option exercise | M | — 1,150 sh | Sep 1, 2026 traded Aug 29, 2026 |